Renal Business Today

Government & Regulation

The End-Stage Renal Disease (ESRD) Program is heavily regulated by the Centers for Medicare & Medicaid Services (CMS), which provides reimbursement to dialysis providers to help pay for the care of kidney disease patients. Kidney-related pharmaceuticals and medical devices are heavily used in dialysis clinics and are also subject to approval and ongoing regulation.

QIP: 10 Least Penalized States

The following slides highlight the 10 states that were least penalized under the new ESRD Quality Incentive Program (QIP). ...More
December 21, 2011
Posted in Galleries, Business, Clinical & Pharma, Government & Regulation, Practice Management
AKF President Named to NIH Council of Councils

WASHINGTON—American Kidney Fund (AKF) President and CEO LaVarne Burton was one of seven new appointments to the National Institutes of Health (NIH) Council of Councils. ...More
December 21, 2011
Posted in News, Business, Government & Regulation
QIP: 10 Most Penalized States

The following slides highlight the 10 states that were most penalized under the new ESRD Quality Incentive Program (QIP). ...More
December 20, 2011
Posted in Galleries, Business, Clinical & Pharma, Government & Regulation, Practice Management
HHS Names 32 Pioneer ACOs

WASHINGTON—The U.S. Department of Health and Human Services (HHS) has named 32 healthcare organizations to be a part of the new Pioneer Accountable Care Organizations (ACOs) initiative ...More
December 19, 2011
Posted in News, Government & Regulation
Dialysis Medicare Margins Tightening

Medicare margins for dialysis clinics fell for all providers in 2010, but they were much tighter for rural clinics and clinics not affiliated with DaVita or Fresenius. ...More
December 16, 2011
Posted in Blog, Government & Regulation, Practice Management
Majority of Dialysis Clinics Don't See QIP Cuts

WASHINGTON—More than two-thirds of U.S. dialysis clinics will not see a payment reduction in 2012 from the new federal pay-for-performance system, according to a Dec. 15 news release from the Centers for Medicare & Medicaid Services (CMS). ...More
December 15, 2011
Posted in News, Government & Regulation, Practice Management
QIP Performance Scores to be Posted

Dialysis clinics should be notified by Dec. 15 about their 2012 Performance Score Certificates (PSC), which must be posted in each facility in clear view of patients and caregivers. ...More
December 15, 2011
Posted in Blog, Government & Regulation, Practice Management
Phase One Receives Second Dialysis Catheter Patent

HINGHAM, Mass.— The U.S. Patent and Trademark Office has issued a second patent covering Phase One Medical's Distal Locking Hemodialysis Catheter Technology. ...More
December 13, 2011
Posted in News, Business, Government & Regulation
Canada Approves Feraheme to Treat CKD Patients

LEXINGTON, Mass.—Health Canada, on Dec. 8 granted marketing approval to AMAG Pharmaceuticals and Takeda Canada for the iron drug Feraheme. ...More
December 12, 2011
Posted in News, Business, Clinical & Pharma, Government & Regulation
FDA Panel Votes in Favor of Affymax Anemia Drug

A federal panel has voted 15-1 in favor of recommending the FDA approval of Affymax's anemia drug peginesatide, according to a Dec. 7 report from the San Francisco Business Times. ...More
December 7, 2011
Posted in Blog, Clinical & Pharma, Government & Regulation